The Division of Hematologic Malignancies and Cellular Therapy (HMCT), in the Department of Medical Oncology, at Thomas Jefferson University, in Philadelphia, PA is looking for a Lymphoma Section Chief to grow and advance the academic and clinical missions of the Division’s Lymphoma Section. The position comes with a leadership role in the Sidney Kimmel Cancer Center (SKCC) clinical trials office (CTO), as Chair of the Lymphoma Multidisciplinary Disease Group (MDG). The Lymphoma Section Chief will also join the recently established SKCC’s Blood Cancer Center of Excellence (BCCE), tasked with the goal to expand and deepen hematologic malignancy research at Jefferson.

The Division of HMCT, based in center city Philadelphia, comprises 16 full time faculty, including two laboratory-based scientists, who are recognized nationally and internationally for excellence in patient care, research and training. Every year, Division faculty and nurses provide complex multidisciplinary and personalized care to patients with all types of hematologic malignancies, including rare and highly complex blood cancers, attracting referrals nationally and internationally.

The Division is a national leader in the development of new therapies for blood cancers, with a pipeline of clinical trials that is managed by three disease-specific (Lymphoma, Myeloma, and Leukemia/MDS) and one modality-specific (BMT/CART) MDGs and includes CART- and CAR-NK cell therapies, molecularly targeted therapies, and novel immunotherapies. The Division’s clinical trial portfolio is further enhanced by an outstanding Phase I program, in academic partnership with the Sarah Cannon Research Institute (SCRI), and a strong and innovative Health Delivery Research effort.

The Division’s translational research mission is supported by the Translational Research Group (TRG) and Biorepository, a CAP-accredited SKCC shared resource that provides tissue, blood, and bone marrow bio-banking services.

The ideal candidate will be an outstanding disease-focused academic physician at the Associate Professor rank, with national reputation and a proven record of success in leading clinical and translational research studies in lymphoma, mentoring, and team building.

The SKCC is an NCI-designated consortium cancer center that includes researchers from Thomas Jefferson University and Drexel University and offers outstanding shared core facilities. Further details can be found at: https://sidneykimmelcancercenter.jeffersonhealth.org/research.html

The SKCC is located in the heart of Philadelphia, a vibrant urban cultural scene with an abundance of opportunities for professional and social interactions. Jefferson values diversity and encourages applications from women, members of minority groups, LGBTQ individuals, disabled individuals, and veterans.

Qualified applicants should submit a single PDF file containing a C.V., contact information for three references, and 2 page programmatic statement.

Inquiries and expressions of interest should be directed to:
[Register to View] style="color:#3366CC;">[Register to View]

Covid Vaccination is a requirement for employment at Jefferson for employees working at Jefferson’s clinical entities or at the University. If you are not currently vaccinated you will be required to receive the vaccination prior to hire date if you are offered employment, unless you request and receive an approved medical or religious exemption from Jefferson.

Jefferson includes Thomas Jefferson University and Jefferson Health, a dynamic university and health system with broad reach across the Delaware Valley. Jefferson is the second largest employer in Philadelphia and the largest health system in Philadelphia based on total licensed beds.

Through the merger of Thomas Jefferson University and Philadelphia University in 2017, our University includes ten colleges and four schools. We are an NCAA Division II university and an R2 national doctoral university offering undergraduate and graduate-level programs that provide students with a forward-thinking education in architecture, business, design, engineering, fashion and textiles, health, medicine and social science.

Jefferson Health, the clinical arm of Thomas Jefferson University, has grown from a three-hospital academic health center in 2015, to an 18-hospital health system through mergers and combinations that include hospitals at Abington Health, Aria Health, Kennedy Health, Magee Rehabilitation and Einstein Healthcare Network. We have over 50 outpatient and urgent care centers; ten Magnet®-designated hospitals (recognized by the ANCC for nursing excellence); the NCI-designated Sidney Kimmel Cancer Center (one of only 70 in the country and one of only two in the region); and one of the largest faculty-based telehealth networks in the country. In 2021, Jefferson Health became the sole owner of HealthPartners Plan, a not-for-profit health maintenance organization in Southeastern Pennsylvania. We are the first health system regionally to create an aligned payer-provider partnership.

Jefferson’s mission, vision and values create an organization that attracts the best and the brightest students, faculty, staff, and healthcare professionals, as well as the most visionary leaders to drive exceptional results.

• OUR MISSION: We improve lives.
• OUR VISION: Reimagining health, education and discovery to create unparalleled value
• OUR VALUES: Put People First, Be Bold & Think Differently and Do the Right Thing

As an employer, Jefferson maintains a commitment to provide equal access to employment. Jefferson values diversity and encourages applications from women, members of minority groups, LGBTQ individuals, disabled individuals, and veterans.